Nkarta(NKTX) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights SOUTH SAN FRANCISCO, Calif., May 14, 2025 -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today reported financial results for the first quarter and year ended March 31, 2025. "Our recent restructuring and continued efforts at cost containment have positioned us well to achieve our clinical milestones while ensuring we have cash to sup ...